Treatment of Ciliopathies: Current Perspectives

Author(s): Christoph Gerhardt .

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 17 , 2019

[1]
Stayner, C.; Brooke, D.; Bates, M.; Eccles, M. Targeted therapies for autosomal dominant polycystic kidney disease. Curr. Med. Chem., 2019, 26(17), 3081-3102.
[2]
Uytingco, C.; Green, W.; Martens, J. Olfactory loss and dysfunction in ciliopathies: Molecular mechanisms and potential therapies. Curr. Med. Chem., 2019, 26(17), 3103-3119.
[3]
Shivanna, M.; Anand, M.; Chakrabarti, S.; Khanna, H. Ocular ciliopathies: genetic and mechanistic insights into developing therapies. Curr. Med. Chem., 2019, 26(17), 3120-3131.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 17
Year: 2019
Page: [3080 - 3080]
Pages: 1
DOI: 10.2174/092986732617190820123648

Article Metrics

PDF: 12
HTML: 3
EPUB: 1